Phase III Study in Refractory Behcet's Disease

NCT00995709 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Behcet Disease

Interventions

DRUG: AIN457
DRUG: AIN457
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals